ciprofloxacin has been researched along with cinnamaldehyde in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Huang, G; Li, X; Ma, R; Ma, S; Sheng, J; Song, D; Yin, F; Zhao, C | 1 |
Jiang, M; Li, S; Li, Z; Wang, H; Yuan, H | 1 |
Dhara, L; Tripathi, A | 1 |
3 other study(ies) available for ciprofloxacin and cinnamaldehyde
Article | Year |
---|---|
Design, synthesis and antibacterial activity of cinnamaldehyde derivatives as inhibitors of the bacterial cell division protein FtsZ.
Topics: Acrolein; Anti-Bacterial Agents; Bacterial Proteins; Cell Division; Cytoskeletal Proteins; Drug Design; Molecular Structure; Staphylococcus aureus | 2015 |
Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids.
Topics: Acrolein; Amino Acids; Anti-Infective Agents; Aspergillus niger; Escherichia coli; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Conformation; Penicillium; Schiff Bases; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Cinnamaldehyde: a compound with antimicrobial and synergistic activity against ESBL-producing quinolone-resistant pathogenic Enterobacteriaceae.
Topics: Acrolein; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins | 2020 |